Browse the full management transaction log of 에스케이바이오팜, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 에스케이바이오팜 has recorded 3 insider filings. Market capitalisation: €7,478.9bn. The latest transaction was reported on 31 March 2026 — Sale. Among the most active insiders: SK. Every trade is accessible without an account.